RecruitingNot ApplicableNCT07728123

Screen2Prevent (S2P)

Screen2Prevent (S2P): Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department


Sponsor

Westat

Enrollment

84,000 participants

Start Date

Jun 16, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).


Eligibility

Min Age: 14 YearsMax Age: 24 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying HIV screening strategies for people with hiv infections. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 14 Years to 24 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHIV screening strategies

The intervention includes three screening strategies (targeted, universally offered opt-in, and universally offered opt-out) which will each be employed, one at a time, for a period of 8 months. A targeted screening approach is defined as screening those who are at increased likelihood for acquiring HIV. Alternatively, a universally offered screening approach is defined as screening all, regardless of behavior informing risk. There are two types of universally offered screening, opt-in and opt-out. With opt-in screening, all patients are offered screening, which they may then agree to undergo. Opt-out screening consists of notifying patients that the test will be conducted unless they explicitly decline. Each screening strategy implements the cSHS, a text messaging platform, and Clinical Decision Support for identification of youth needing HIV treatment/prevention and linkage to services.


Locations(5)

University of South Florida

Tampa, Florida, United States

Emory Atlanta Adolescent Consortium

Atlanta, Georgia, United States

Johns Hopkins University

Baltimore, Maryland, United States

St. Jude Children's Research Hospital

Memphis, Tennessee, United States

Baylor College of Medicine

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07728123


Related Trials